PENUMBRA INC (PEN) Fundamental Analysis & Valuation

NYSE:PEN • US70975L1070

Current stock price

333.4 USD
+1.19 (+0.36%)
Last:

This PEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PEN Profitability Analysis

1.1 Basic Checks

  • In the past year PEN was profitable.
  • PEN had a positive operating cash flow in the past year.
  • Of the past 5 years PEN 4 years were profitable.
  • Of the past 5 years PEN 4 years had a positive operating cash flow.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • PEN's Return On Assets of 9.73% is amongst the best of the industry. PEN outperforms 89.84% of its industry peers.
  • PEN has a better Return On Equity (12.45%) than 87.17% of its industry peers.
  • PEN's Return On Invested Capital of 8.85% is amongst the best of the industry. PEN outperforms 87.17% of its industry peers.
  • PEN had an Average Return On Invested Capital over the past 3 years of 6.23%. This is below the industry average of 9.12%.
  • The 3 year average ROIC (6.23%) for PEN is below the current ROIC(8.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROIC 8.85%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • PEN's Profit Margin of 12.66% is amongst the best of the industry. PEN outperforms 86.10% of its industry peers.
  • PEN has a better Operating Margin (13.48%) than 82.35% of its industry peers.
  • PEN's Operating Margin has improved in the last couple of years.
  • The Gross Margin of PEN (67.14%) is better than 72.73% of its industry peers.
  • PEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PEN Health Analysis

2.1 Basic Checks

  • PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PEN has been increased compared to 1 year ago.
  • The number of shares outstanding for PEN has been increased compared to 5 years ago.
  • PEN has a better debt/assets ratio than last year.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 21.62 indicates that PEN is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 21.62, PEN belongs to the best of the industry, outperforming 95.72% of the companies in the same industry.
  • PEN has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
  • The Debt to FCF ratio of PEN (0.13) is better than 92.51% of its industry peers.
  • PEN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • PEN's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. PEN outperforms 71.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 21.62
ROIC/WACC0.99
WACC8.93%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • PEN has a Current Ratio of 6.64. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • PEN's Current ratio of 6.64 is amongst the best of the industry. PEN outperforms 83.42% of its industry peers.
  • PEN has a Quick Ratio of 4.29. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PEN (4.29) is better than 74.33% of its industry peers.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 4.29
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PEN Growth Analysis

3.1 Past

  • PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.80%, which is quite impressive.
  • The Earnings Per Share has been growing by 84.42% on average over the past years. This is a very strong growth
  • The Revenue has grown by 17.50% in the past year. This is quite good.
  • Measured over the past years, PEN shows a very strong growth in Revenue. The Revenue has been growing by 20.16% on average per year.
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%

3.2 Future

  • PEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.81% yearly.
  • The Revenue is expected to grow by 13.43% on average over the next years. This is quite good.
EPS Next Y32.74%
EPS Next 2Y29.82%
EPS Next 3Y26.72%
EPS Next 5Y23.81%
Revenue Next Year14.81%
Revenue Next 2Y14.26%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. PEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 86.82, which means the current valuation is very expensive for PEN.
  • Based on the Price/Earnings ratio, PEN is valued a bit cheaper than the industry average as 65.78% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.50, PEN is valued quite expensively.
  • The Price/Forward Earnings ratio is 65.41, which means the current valuation is very expensive for PEN.
  • Based on the Price/Forward Earnings ratio, PEN is valued a bit cheaper than the industry average as 67.91% of the companies are valued more expensively.
  • PEN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.62.
Industry RankSector Rank
PE 86.82
Fwd PE 65.41
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PEN is valued a bit cheaper than the industry average as 66.31% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than 70.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 74.94
EV/EBITDA 58.93
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
  • PEN has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as PEN's earnings are expected to grow with 26.72% in the coming years.
PEG (NY)2.65
PEG (5Y)1.03
EPS Next 2Y29.82%
EPS Next 3Y26.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PEN Dividend Analysis

5.1 Amount

  • No dividends for PEN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PEN Fundamentals: All Metrics, Ratios and Statistics

PENUMBRA INC

NYSE:PEN (4/23/2026, 3:45:00 PM)

333.4

+1.19 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners94.76%
Inst Owner Change0.01%
Ins Owners2.95%
Ins Owner Change1.13%
Market Cap13.11B
Revenue(TTM)1.40B
Net Income(TTM)177.69M
Analysts70
Price Target375.96 (12.77%)
Short Float %6.42%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.62%
Min EPS beat(2)4.22%
Max EPS beat(2)5.02%
EPS beat(4)4
Avg EPS beat(4)9.18%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)10.88%
EPS beat(12)12
Avg EPS beat(12)25.19%
EPS beat(16)15
Avg EPS beat(16)21.43%
Revenue beat(2)2
Avg Revenue beat(2)3.54%
Min Revenue beat(2)3.05%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)2.83%
Min Revenue beat(4)1.67%
Max Revenue beat(4)4.03%
Revenue beat(8)7
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)1.44%
Revenue beat(16)12
Avg Revenue beat(16)1.32%
PT rev (1m)2.73%
PT rev (3m)9.73%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)-1.77%
EPS NY rev (1m)-0.33%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.82%
Valuation
Industry RankSector Rank
PE 86.82
Fwd PE 65.41
P/S 9.34
P/FCF 74.94
P/OCF 54.93
P/B 9.18
P/tB 10.45
EV/EBITDA 58.93
EPS(TTM)3.84
EY1.15%
EPS(NY)5.1
Fwd EY1.53%
FCF(TTM)4.45
FCFY1.33%
OCF(TTM)6.07
OCFY1.82%
SpS35.7
BVpS36.31
TBVpS31.91
PEG (NY)2.65
PEG (5Y)1.03
Graham Number56.0085 (-83.2%)
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROCE 11.52%
ROIC 8.85%
ROICexc 13.24%
ROICexgc 15.72%
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
FCFM 12.46%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
ROICexc(3y)8.66%
ROICexc(5y)5.61%
ROICexgc(3y)10.48%
ROICexgc(5y)6.87%
ROCE(3y)8.11%
ROCE(5y)5.29%
ROICexgc growth 3Y198.14%
ROICexgc growth 5YN/A
ROICexc growth 3Y208.33%
ROICexc growth 5YN/A
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.1
Cap/Depr 364.77%
Cap/Sales 4.54%
Interest Coverage 250
Cash Conversion 115.45%
Profit Quality 98.45%
Current Ratio 6.64
Quick Ratio 4.29
Altman-Z 21.62
F-Score7
WACC8.93%
ROIC/WACC0.99
Cap/Depr(3y)169.98%
Cap/Depr(5y)143.68%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.57%
Profit Quality(3y)413.32%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
EPS Next Y32.74%
EPS Next 2Y29.82%
EPS Next 3Y26.72%
EPS Next 5Y23.81%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%
Revenue Next Year14.81%
Revenue Next 2Y14.26%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%
EBIT growth 1Y58.26%
EBIT growth 3Y214.22%
EBIT growth 5YN/A
EBIT Next Year68.35%
EBIT Next 3Y32.28%
EBIT Next 5Y26.71%
FCF growth 1Y18.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.66%
OCF growth 3YN/A
OCF growth 5YN/A

PENUMBRA INC / PEN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PEN.


What is the valuation status for PEN stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


How profitable is PENUMBRA INC (PEN) stock?

PENUMBRA INC (PEN) has a profitability rating of 8 / 10.


What is the valuation of PENUMBRA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for PENUMBRA INC (PEN) is 86.82 and the Price/Book (PB) ratio is 9.18.


Can you provide the financial health for PEN stock?

The financial health rating of PENUMBRA INC (PEN) is 8 / 10.